Cargando…

Histone deacetylase 6 in cancer

Histone acetylation and deacetylation are important epigenetic mechanisms that regulate gene expression and transcription. Histone deacetylase 6 (HDAC6) is a unique member of the HDAC family that not only participates in histone acetylation and deacetylation but also targets several nonhistone subst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ting, Zhang, Chao, Hassan, Shafat, Liu, Xinyue, Song, Fengju, Chen, Kexin, Zhang, Wei, Yang, Jilong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122547/ https://www.ncbi.nlm.nih.gov/pubmed/30176876 http://dx.doi.org/10.1186/s13045-018-0654-9

Ejemplares similares

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
por: Beljkas, Milan, et al.
Publicado: (2023)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Zinc binding groups for histone deacetylase inhibitors
por: Zhang, Lei, et al.
Publicado: (2018)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

The role of T-box genes in the tumorigenesis and progression of cancer
por: Chang, Fangyuan, et al.
Publicado: (2016)

Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Targeted inhibition of histone deacetylase 6 in inflammatory diseases
por: Ran, Jie, et al.
Publicado: (2019)

BRAF mutation and its inhibitors in sarcoma treatment
por: Liu, Haotian, et al.
Publicado: (2020)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 modulates macrophage infiltration during inflammation
por: Yan, Bing, et al.
Publicado: (2018)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
por: Xu, Long, et al.
Publicado: (2023)

Targeting histone deacetylases for cancer therapy: Trends and challenges
por: Liang, Tao, et al.
Publicado: (2023)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Involvement of Arabidopsis histone deacetylase HDA6 in ABA and salt stress response
por: Chen, Li-Ting, et al.
Publicado: (2010)

Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90
por: Liu, Ping, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
por: Wawruszak, Anna, et al.
Publicado: (2019)

Role of Natural Products in Modulating Histone Deacetylases in Cancer
por: Merarchi, Myriam, et al.
Publicado: (2019)

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
por: Ruzic, Dusan, et al.
Publicado: (2022)

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
por: Badie, Amandine, et al.
Publicado: (2022)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
por: Li, Guo, et al.
Publicado: (2020)

Histone deacetylases as targets for antitrypanosomal drugs
por: Zuma, Aline A, et al.
Publicado: (2018)

Clinical Toxicities of Histone Deacetylase Inhibitors
por: Subramanian, Srividya, et al.
Publicado: (2010)

Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009)

Histone Deacetylase Inhibitors as Anticancer Drugs
por: Eckschlager, Tomas, et al.
Publicado: (2017)

Dysregulation of Histone Acetyltransferases and Deacetylases in Cardiovascular Diseases
por: Wang, Yonggang, et al.
Publicado: (2014)

Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis
por: Jiang, Li-Ping, et al.
Publicado: (2022)

The Role of Histone Acetyltransferases and Histone Deacetylases in Photoreceptor Differentiation and Degeneration
por: Zhao, Meng, et al.
Publicado: (2020)

Histone acetylation and the role of histone deacetylases in normal cyclic endometrium
por: Gujral, Palak, et al.
Publicado: (2020)

Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma
por: Guo, Shan-qi, et al.
Publicado: (2012)

Virtual screening and experimental validation of novel histone deacetylase inhibitors
por: Huang, Yan-xin, et al.
Publicado: (2016)

Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas
por: Zhang, Qing, et al.
Publicado: (2019)

Targeting Histone Deacetylases for Cancer Therapy: From Molecular Mechanisms to Clinical Implications
por: Li, Zhiming, et al.
Publicado: (2014)

Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor
por: Zhou, Wenya, et al.
Publicado: (2016)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
por: Hai, Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iagd8iv9gp4hmchhajks9ptasf